| Bioactivity | Alogabat (example 8) is a GABAA α5 receptor positive allosteric modulators (PAMs) (extracted from patent WO2018104419A1)[1]. | ||||||||||||
| Name | Alogabat | ||||||||||||
| CAS | 2230009-48-8 | ||||||||||||
| Formula | C21H23N5O4 | ||||||||||||
| Molar Mass | 409.44 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Bernd Buettelmann, et al. New isoxazolyl ether derivatives as gaba a alpha5 pam. Patent WO2018104419A1. |
Alogabat
CAS: 2230009-48-8 F: C21H23N5O4 W: 409.44
Alogabat (example 8) is a GABAA α5 receptor positive allosteric modulators (PAMs) (extracted from patent WO2018104419A1
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.